Search
for
Sort by
Research 661–690 of 1000+
- Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies
- How Does Altered Metabolism Lead to Seizure Control? Partially Filling the Knowledge Gap
- Evaluation of Serum Vitamin-D Levels in Patients with Alopecia Areata
- Prevalence of androgenic alopecia (AGA) in patients with polycystic ovarian syndrome (PCOS) and characterization of associated clinical and biochemical features
- Neurosteroids on the Epilepsy Chessboard—Keeping Seizures in Check
- Toxic epidermal necrolysis due to cephalexin
- Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome
- A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive.
- Relationship Between Steroid Hormones and Metabolic Profile in Women With Polycystic Ovary Syndrome
- Metabolic dysfunction in obese Hispanic women with polycystic ovary syndrome
- A New Heterozygous Variant of c.1225_1227delTTC (p.Phe409del) in Insulin Receptor Gene Associated with Severe Insulin Resistance and Hyperandrogenemia in an Adolescent Female with Type A Severe Insulin Resistance Syndrome
- Salivary Inflammatory Markers and Free Androgen Index in Women with Polycystic Ovary Syndrome: A Case-Control Study
- From Hairline to Lipid Line: Prevalence and Spectrum of Dyslipidemia in Patients with Androgenetic Alopecia – A Hospital-Based Study
- Differential plasma proteome analysis reveals key proteins associated with insulin resistance in acne vulgaris patients
- Early onset androgenic alopecia as the male phenotypic equivalent of polycystic ovarian syndrome is associated in high oxidative stress
- Insulin resistance and metabolic syndrome in female androgenetic alopecia
- Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients
- Is dehydroepiandrosterone a hormone?
- Timing of expression of the core clock gene <i>Bmal1</i> influences its effects on aging and survival
- Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence
- Associaton of Insulin Resistance Linked Diseases and Hair Loss in Elderly Men. Finnish Population-based Study
- Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women
- The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia
- Tofacitinib for the treatment of alopecia areata in preadolescent children
- Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical signs are oligo/anovulation or hirsutism
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- Androgenetic alopecia and insulin resistance: are they truly associated?
- Hypothyroidism in Thyroid Carcinoma Follow-up: Orlistat May Inhibit the Absorption of Thyroxine
- A Comprehensive Approach in Diagnosing the Polycystic Ovary Syndrome
- Central Diabetes Insipidus and Hypothalamic Type of Hypopituitarism Associated with Atypical Location of Rathke's Cleft Cyst